COVID-19 pharmacotherapy: present and future

The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics

Source: © Royal Society of Chemistry

An overview of potential therapeutic interventions encompassing the approved, proposed, repurposed, and the experimental

Sign in to read the full-text of this chapter for free. Don’t have an account? Register now.

The COVID-19 pandemic has raised unprecedented challenges for humans. The entire process of scientific discovery, trials, and the research associated with it is ever-expanding and poses a daunting task for researchers and drug developers. The fast-tracking of treatments has become imperative in these times of pandemic emergency. The initiatives by FDA such as CTAP (Corona Treatment Accelerating Program) and the ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) pursued by NIH, along-with the various efforts across the globe, demonstrate that we must be united in moving toward the goal of ending this pandemic. In this chapter, we have tried to review and summarize potential therapeutic interventions encompassing the approved, proposed, repurposed, and experimental ones.

Read the full text of this chapter for free

How it works

Full-text chapters of books are available for free to our readers and members of the Royal Society of Chemistry. You need to sign in with your Chemistry World account or with your membership details to gain access. Don't have an account? Register now.


Get access to full-text book chapters. You'll also be able to read more articles each month before you see another paywall. It takes less than a minute and it's completely free.


Included as a benefit
Members of the Royal Society of Chemistry have unlimited access to Chemistry World as a benefit of membership - including our full-text book chapters. Just sign in with your usual membership credentials. Not a member? Find out how to join.